Technology / Scientific & Technical InstrumentsNasdaqCM
$4.16
-0.42 (-9.17%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-10.1M · quality 62.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
24/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$70M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-67.0%
↓Gross Margin
28.9%
↓Debt/Equity
0.03
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2013–2025 · 12 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
-456.4%
FCF / Net income
0.81x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.0M · net income $-17.0M · FCF $-13.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | $3.0M | $3.0M | $4.0M | $3.0M | $665000.00 | $387000.00 | $491000.00 | $309000.00 | $391000.00 | — | — | — | — | — |
| Net Income | $-17.0M | $-17.0M | $-11.8M | $-9.4M | $-9.5M | $-9.0M | $-4.7M | $-1.8M | $-524000.00 | $13818.00 | $-64310.00 | $-25304.00 | $-39682.00 | — |
| EBITDA | $-18.0M | $-18.0M | $-12.4M | $-10.3M | $-9.2M | — | — | — | — | — | — | — | — | — |
| EPS | — | — | -1.03 | -0.98 | -1.33 | -1.44 | — | — | — | — | — | — | — | — |
| Gross Margin | 28.9% | 28.9% | 29.2% | 16.8% | -145.3% | -186.3% | -102.4% | -75.4% | 43.5% | — | — | — | — | — |
| Operating Margin | -601.5% | -601.5% | -315.5% | -350.6% | -1419.4% | -2354.5% | -958.5% | -584.8% | -133.8% | — | — | — | — | — |
| Net Margin | -565.0% | -565.0% | -296.8% | -311.4% | -1423.8% | -2322.2% | -950.5% | -591.9% | -134.0% | — | — | — | — | — |
| Balance Sheet | ||||||||||||||
| Debt/Equity | 0.03 | 0.03 | 0.06 | 0.07 | 0.02 | — | — | — | — | — | — | — | — | — |
| Current Ratio | 7.80 | 7.80 | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||
| Free Cash Flow | $-13.8M | $-13.8M | $-8.3M | $-10.1M | $-6.2M | $-6.5M | $-4.5M | $-1.9M | — | — | — | — | — | — |
| Returns | ||||||||||||||
| ROE | -67.0% | -67.0% | -64.5% | -53.0% | -80.3% | -45.8% | -117.7% | -72.5% | 444.1% | -31.2% | 110.6% | -410.6% | -126.1% | — |
| Valuation | ||||||||||||||
| P/B | 2.68 | 2.68 | 5.61 | 1.63 | 3.02 | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||
| Revenue Growth | -23.9% | -23.9% | 30.7% | 356.1% | — | -21.2% | 58.9% | -21.0% | — | — | — | — | — | — |
| EPS Growth | — | — | -5.1% | 26.3% | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-23.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-1.03 → n/d
Residual
-23.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.